BWX Technologies, Inc. (NYSE:BWXT) Short Interest Update

BWX Technologies, Inc. (NYSE:BWXT) was the recipient of a significant increase in short interest during the month of March. As of March 13th, there was short interest totaling 2,832,475 shares, an increase of 20.5% from the February 26th total of 2,350,109 shares. Currently, 3.1% of the shares of the stock are short sold. Based on an average daily trading volume, of 1,025,964 shares, the short-interest ratio is presently 2.8 days.

BWX Technologies Price Performance

BWX Technologies stock opened at $212.99 on Thursday. The firm has a 50-day moving average price of $203.66 and a 200-day moving average price of $193.57. The firm has a market capitalization of $19.51 billion, a PE ratio of 59.66, a price-to-earnings-growth ratio of 3.53 and a beta of 0.80. The company has a current ratio of 2.32, a quick ratio of 2.25 and a debt-to-equity ratio of 1.64. BWX Technologies has a 12-month low of $84.21 and a 12-month high of $222.29.

BWX Technologies (NYSE:BWXT) last issued its quarterly earnings results on Monday, February 23rd. The technology company reported $1.08 EPS for the quarter, beating the consensus estimate of $0.91 by $0.17. BWX Technologies had a net margin of 10.28% and a return on equity of 30.94%. The company had revenue of $885.84 million for the quarter, compared to the consensus estimate of $837.47 million. During the same period in the prior year, the firm posted $0.92 EPS. The firm’s revenue was up 18.7% compared to the same quarter last year. BWX Technologies has set its FY 2026 guidance at 4.550-4.700 EPS. As a group, equities research analysts forecast that BWX Technologies will post 3.23 EPS for the current year.

BWX Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, March 27th. Stockholders of record on Wednesday, March 11th were paid a dividend of $0.27 per share. This is a positive change from BWX Technologies’s previous quarterly dividend of $0.25. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend was Wednesday, March 11th. BWX Technologies’s payout ratio is currently 30.25%.

Insider Transactions at BWX Technologies

In other BWX Technologies news, CAO Kevin James Gorman sold 1,344 shares of BWX Technologies stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $214.71, for a total value of $288,570.24. Following the sale, the chief accounting officer directly owned 114 shares in the company, valued at approximately $24,476.94. The trade was a 92.18% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Rex D. Geveden sold 10,000 shares of the business’s stock in a transaction on Thursday, February 12th. The stock was sold at an average price of $203.26, for a total transaction of $2,032,600.00. Following the completion of the sale, the chief executive officer owned 177,594 shares in the company, valued at approximately $36,097,756.44. The trade was a 5.33% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 13,327 shares of company stock valued at $2,734,844. 0.47% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On BWX Technologies

A number of institutional investors and hedge funds have recently modified their holdings of the business. Goldman Sachs Group Inc. grew its position in BWX Technologies by 0.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 141,680 shares of the technology company’s stock valued at $13,977,000 after acquiring an additional 371 shares during the last quarter. Caxton Associates LLP bought a new stake in shares of BWX Technologies during the first quarter worth $304,000. Choreo LLC bought a new stake in shares of BWX Technologies during the second quarter worth $216,000. Quadrant Capital Group LLC boosted its stake in shares of BWX Technologies by 624.7% during the second quarter. Quadrant Capital Group LLC now owns 5,225 shares of the technology company’s stock valued at $753,000 after purchasing an additional 4,504 shares during the period. Finally, Elevation Point Wealth Partners LLC purchased a new stake in shares of BWX Technologies during the second quarter valued at $93,000. 94.39% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on BWXT shares. Weiss Ratings upgraded BWX Technologies from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, February 25th. Truist Financial set a $205.00 price objective on BWX Technologies in a report on Friday, January 9th. Wall Street Zen downgraded BWX Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, February 28th. Wells Fargo & Company began coverage on shares of BWX Technologies in a report on Wednesday. They issued an “underweight” rating and a $200.00 target price for the company. Finally, Bank of America boosted their price target on shares of BWX Technologies from $230.00 to $250.00 and gave the stock a “buy” rating in a research report on Wednesday, March 25th. Three equities research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $207.60.

BWX Technologies Company Profile

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.